Dear Secretary Collins, The American Pharmacists Association (APhA) appreciates the opportunity to provide the Department of Veterans Affairs (VA) with comments on the "Expanding Access to State Prescription Drug Monitoring Programs," proposed rule. APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.
Expanding Access to State Prescription Drug Monitoring Programs (AS73)
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Jul 21, 2026 and Jul 21, 2026. 1 other organizations filed here. The comment window closed 8d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
The Department of Veterans Affairs (VA) proposes to amend its regulations that govern participation in State prescription drug monitoring programs. This proposed rulemaking would implement the mandates of the VA MISSION Act of 2018 by granting VA licensed health care providers and delegates access to the national network of State-based prescription drug monitoring programs irrespective of any State law, rule, or regulation that would otherwise restrict such access. This proposed rulemaking would also broaden VA’s authority to disclose information to State-based prescription drug monitoring programs. The proposed rulemaking would promote safe and effective prescribing of controlled substances to beneficiaries of VA health care.
View on regulations.gov →Co-filers (1)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- National Association of Boards of Pharmacy on VA-2026-VHA-0166-0001trade assoc.1 filing · confidence 85%